Mark Myron is an expert in the field of Hematology. He went to University of Kansas School of Medicine. He has 2 awards "Regional Top Doctor" and "Super Doctor". Mark Myron is also a published doctor. He has 2 publication published. The most recent publication is: The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer. He is registered with Medicare.
University of Kansas School of Medicine
University of Colorado
University of Missouri-Columbia School of Medicine| NPI NUMBER | 1902878309 | |
| NPPES Provider LastName | MYRON | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 662104045 | |
| NPPES Provider State | KS | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 615.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 100.0 | |
| Percent Opioid Claims | 16.26 |
| National Provider Identifier [NPI] | 1902878309 |
| Last Name Of The Provider | MYRON |
| First Name Of The Provider | MARK |
| View All |
|
Dr. Gregory J. Crane, MD
This Doctor is OpenDoctor Recommended.
|
|
Brooke Loo, PA
This Doctor is OpenDoctor Recommended.
|
|
Dr. Galen M. Custer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Laxmidas A. Sawkar, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Barry S. Skikne, MB CHB
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Joseph Stilwill, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Elizabeth W. Ng, MD
This Doctor is OpenDoctor Recommended.
|